BLAU3.SA Blau Farmacêutica S.A

Healthcare Pharmaceuticals Sao Paulo Exchange
8.63 BRL
Close of Nov 5, 2026
8.22 14.17
Market cap
BRL 1.99B
P/E
6.6x
P/B
0.86x
ROE
8.0%
Dividend yield
4.11%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is BLAU3.SA undervalued?

Graham number
Price8.63
Graham value17.09
Discount49.5%

BLAU3.SA trades 49.5% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Blau Farmacêutica S.A fundamental analysis

No fundamental analysis for Blau Farmacêutica S.A yet.

Blau Farmacêutica S.A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Blau Farmacêutica S.A

Blau Farmacêutica S.A., a pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its products cover various areas, such as immunology, hematology, oncology, nephrology, infectology, and anesthesiology. The company offers uterine stimulator, antirheumatic, anaesthetics, antibiotics, feminine health care, biopharmaceuticals, oncologicals, hospital products, antivirals and antiretrovirals, biológicos, …

Full company profile